Get started
RESVERLOGIX CORP COM NPVRESVERLOGIX CORP COM NPVRESVERLOGIX CORP COM NPV

RESVERLOGIX CORP COM NPV

No trades
See on Supercharts
Overview
Financials
News Ideas Discussions Technicals Seasonals

0VF9 fundamentals

Key facts

Market capitalization—
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)—
Founded—
Employees (FY)—
CEO—
Website—
About

Resverlogix Corp. engages in the research and development of pharmaceutical products for cardiovascular diseases. It develops Apabetalone for diabetes mellitus, chronic kidney, peripheral artery, Orphan, and Alzheimer's diseases. The company was founded by Donald J. McCaffrey and Norman C. W. Wong on August 17, 2000 and is headquartered in Calgary, Canada.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
0VF9 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company